- NZ$9.80m
- NZ$9.42m
- NZ$1.51m
Brief: Cann Group Says To Defend Legal Proceedings Brought By Rua Biosciences
Brief: Rua Bioscience Commences Legal Proceedings Against Cann Group
NZ's Rua Bioscience scales 2-month high on agreement with Apollo Green
Brief: Rua Bioscience Expands International Reach To Canada
Brief: Rua Bioscience Expands Global Reach With UK Distribution Agreement
Brief: Rua Bioscience Says There Have Been Recent Quality Issues With Cann's Export Products
Brief: Rua Bioscience Says Supply Line Strengthens With Schroll Medical Agreement
Brief: Rua Bioscience Posts Loss Before Tax For FY23 NZ$6 Million
Brief: Rua Bioscience Getts Australian Licences For Wholesale, Trade Activities Of Medicinal Cannabis
Brief: Rua Bioscience Says Introduced A Branded Product In Germany
Brief: Rua Bioscience Says Resignation Of Chief Financial Officer, Hamish White
Brief: Rua Bioscience Says First Medicinal Cannabis Dossier For Polish Market Has Now Been Submitted
Brief: Rua Bioscience Says Will Cease Local GMP Manufacturing
Brief: Rua Bioscience Says Anna Stove's Tenure As Managing Director Has Ended
Brief: Rua Bioscience Signs Five-Year Master Supply Agreement With Motagon
Brief: Rua Bioscience Says Rua's R+D Facility At Ruatorea Remains Operational
Brief: Rua Bioscience Says Appointed Paul Naske As Chief Executive Officer
Brief: Rua Bioscience Says It Got First Order Via Nimbus Health
Brief: Rua Bioscience Says Anna Stove Will Lead Business While Board Looks To Appoint New CEO